Determinants of life satisfaction in inflammatory bowel disease. - Wikidata - awgldk - TriplyDB

Determinants of life satisfaction in inflammatory bowel disease.

Determinants of life satisfaction in inflammatory bowel disease.

http://www.wikidata.org/entity/Q51932708

about

The impact of biological interventions for ulcerative colitis on health-related quality of life The impact of biological interventions for ulcerative colitis on health-related quality of life The impact of medical interventions for ulcerative colitis on health-related quality of life Psychosocial issues in evidence-based guidelines on inflammatory bowel diseases: a review Preventive health measures in inflammatory bowel disease Getting personal: a review of sexual functioning, body image, and their impact on quality of life in patients with inflammatory bowel disease Anxiety and depression in adult patients with celiac disease on a gluten-free diet.Quality of life in patients with ulcerative colitis treated surgically.Perception gaps between patients with ulcerative colitis and healthcare professionals: an online survey Measuring patients' satisfaction with their anti-TNF treatment in severe Crohn's disease: scoring and psychometric validation of the Satisfaction for PAtients in Crohn's diseasE Questionnaire (SPACE-Q(©)).The impact of biologics on health-related quality of life in patients with inflammatory bowel disease.Optimizing management of Crohn's disease within a project management framework: results of a pilot study.Comorbidity in inflammatory bowel disease.Randomized trial of tofacitinib in active ulcerative colitis: analysis of efficacy based on patient-reported outcomes The relationship among multiple patient-reported outcomes measures for patients with ulcerative colitis receiving treatment with MMX ® formulated delayed-release mesalamine Associations of sense of coherence with psychological distress and quality of life in inflammatory bowel disease Update on the management of ulcerative colitis: treatment and maintenance approaches focused on MMX(®) mesalamine.Efficacy of duloxetine add on in treatment of inflammatory bowel disease patients: A double-blind controlled study.Randomised trial of once- or twice-daily MMX mesalazine for maintenance of remission in ulcerative colitis.Quality of life of patients with ulcerative colitis: past, present, and future.Mesalamine with MMX technology for the treatment of ulcerative colitis.Depression and anxiety in inflammatory bowel disease: a review of comorbidity and management.Patient considerations in the management of ulcerative colitis: role of once-daily MMX mesalamine.General health maintenance in IBD.Need for standardization in population-based quality of life studies: a review of the current literature.Serologic markers: impact on early diagnosis and disease stratification in inflammatory bowel disease.Managing pain in inflammatory bowel disease.Second European evidence-based consensus on the diagnosis and management of ulcerative colitis part 3: special situations.Impact of drug therapy and surgery on quality of life in Crohn's disease: a systematic review.A case-control study of current psychological well-being and weight-teasing history in young adults with and without bowel conditions.Prevalence of depression and depressive symptoms among outpatients: a systematic review and meta-analysis.A longitudinal study of the profiles of psychological thriving, resilience, and loss in people with inflammatory bowel disease.Controversies Revisited: A Systematic Review of the Comorbidity of Depression and Anxiety with Inflammatory Bowel Diseases.An 18-month study of the effects of IBD symptomatology and emotion regulation on depressed mood.Inflammatory bowel disease: The harmful mechanism of experiential avoidance for patients' quality of life.The impact of MMX mesalazine on disease-specific health-related quality of life in ulcerative colitis patients.Impact of MMX® mesalamine on improvement and maintenance of health-related quality of life in patients with ulcerative colitis.Factors associated with depression among individuals with chronic fatigue syndrome: findings from a nationally representative survey.Effect of extended MMX mesalamine therapy for acute, mild-to-moderate ulcerative colitis.Gender differences in inflammatory bowel disease: Explaining body image dissatisfaction.

P2860

Q24187078-D29B1F63-2CFD-404A-941E-9AEE6BBB187C Q24202509-EE16D789-CC2C-4285-8DA4-A5788265417D Q24235864-2905D842-082E-43D6-9D47-C571277CAC0F Q26827581-07087A50-4B94-40BB-9B43-C3BBCCF2C5A7 Q28078112-D5B2A8F5-27BB-4A21-866D-FCA022640865 Q28081954-0CBA138C-46A8-4155-B972-DFD4F7873BA3 Q33903621-AE75C21E-1FD4-47EB-A6F8-DE1867182108 Q34258138-B4B42E5F-BFE8-481B-8BF9-8236FB063A92 Q34380612-22FA9166-9D19-4CA3-98D3-A9163891C6EB Q34671143-4CBB2336-04F2-4910-9624-588A50D6E473 Q35026298-2180A62A-028A-4B2D-92A1-9B5260009324 Q35036687-AA1DA3C7-6237-4B39-B58B-E577F0A9C257 Q35065318-5FEEF426-F64E-4E8B-96D1-72F12665195A Q35068784-114E099B-1FE3-4B7E-B7F1-763712850235 Q35148270-724A4E94-EE50-4543-88B0-2B9CC6D6B6FA Q35692347-D667EE40-3BF1-42D4-BAD0-736C421B4A3A Q36144377-A34DA874-0617-4447-9884-AF9A6770093E Q36210044-94FF0A24-BCDE-4227-A844-DBB3C0F1A7E9 Q36930800-541FBBE7-3757-4EEC-A562-99BF861D5F55 Q36987080-CDD03BE1-BDEC-4D84-8EC2-84267E58D863 Q37345925-F71FE3BC-EFA3-4E17-9E56-1EB8FC700BC0 Q37374868-0402C3DA-D75D-40D9-BA3E-7C8826B141AE Q37423752-D8F03708-4E48-4713-8555-E3E4404EFD32 Q37547079-3D74E1DC-4B22-4386-B755-0603468B7062 Q37564287-DD3466E6-A8B5-4344-AF77-B320EB9F22DE Q37777013-11F6FBBB-C945-4871-8827-050450E762F9 Q37980743-69F1D131-55B3-407E-8171-1460F347EBFC Q38049779-D96882D7-0A7E-40A8-BB69-ED5C2DBDB3A1 Q38430984-F8C20707-6E81-4D6F-BD84-AEB03D46DB0E Q38547961-18A1A324-E714-4C01-911E-A55386554C6E Q38609518-677F3B0A-BEAC-4D0A-B38B-E10C7B47C41E Q38626450-76FE010F-F055-4A5B-A35F-01DBE01ADF95 Q38721699-A065CE3D-6AEB-4682-936A-573125ABA3B3 Q38968641-CC067D47-BC80-42DA-974B-5F6FEBA6B4F2 Q40868361-E87B8423-D6E7-41EF-BFB1-FF49B79B5A18 Q42645787-E3B80584-EB41-4875-A4E0-2BCFEB11F2BC Q42651189-91FF4704-B54C-4182-8A81-59C8A666C8D9 Q44775045-CBBA2901-19E5-4A80-B7A9-36FFF75D8023 Q46452033-A53D6397-DD18-4851-8D20-8A5E5F9243DF Q47569263-0F785816-86DD-46CC-B188-D751D301F2A3

P2860

Determinants of life satisfaction in inflammatory bowel disease.

http://www.wikidata.org/entity/Q51932708

description

2005 nî lūn-bûn

@nan

2005年の論文

@ja

2005年学术文章

@wuu

2005年学术文章

@zh

2005年学术文章

@zh-cn

2005年学术文章

@zh-hans

2005年学术文章

@zh-my

2005年学术文章

@zh-sg

2005年學術文章

@yue

2005年學術文章

@zh-hant

name

Determinants of life satisfaction in inflammatory bowel disease.

@en

Determinants of life satisfaction in inflammatory bowel disease.

@nl

type

label

Determinants of life satisfaction in inflammatory bowel disease.

@en

Determinants of life satisfaction in inflammatory bowel disease.

@nl

prefLabel

Determinants of life satisfaction in inflammatory bowel disease.

@en

Determinants of life satisfaction in inflammatory bowel disease.

@nl

P1433

Q51932708-B6ECB97A-E3E3-40EA-92B7-46F5A14B4D01

P1476

Q51932708-39EDAB35-013C-45A1-9DC5-711CC7D64F89

P2093

Q51932708-132C500D-0774-4E84-AC3B-DB6B2B88FCB1

Q51932708-1D2BC348-E87E-420A-BAAB-ACE85A016948

Q51932708-88507B86-A495-4C2D-A8AA-F38DB8380FEA

Q51932708-AF4FE05E-9F90-4655-AA0E-65E96C636380

Q51932708-C50C28DE-C373-4ED9-8F9C-F5D500E6D9DD

P2860

Q51932708-0002BA9C-1C04-4DDA-9F57-C46870B0FF39

Q51932708-08D3ECA0-DD5A-4945-9D34-B33D3BA1A277

Q51932708-0F01D33A-5120-48B8-ADB8-A7B94D77F55D

Q51932708-13B4FD5D-BF24-400A-92B5-CFA4F6859EBC

Q51932708-514FAE4F-444C-4902-9356-3AC69D8492BE

Q51932708-58188227-50F2-4C41-8979-EC4AEEDEEFD9

Q51932708-5C9216A9-1713-42B0-B9C7-C794F719CBC6

Q51932708-9DD474AB-830A-4F63-A53A-8D8747C6A497

Q51932708-A63863A3-C885-47BD-B987-3B0349C92404

Q51932708-A92B060C-178A-4D1D-A8CE-13F4E28FB593

P304

Q51932708-CE114C41-6C6D-4F93-9F0F-B370E664FBA6

P31

Q51932708-F6571E9C-CC39-45F0-960A-6398389B1D2F

P356

Q51932708-DAF9BED1-559D-43B2-85C1-CF953AAD7A22

P433

Q51932708-D7F484D7-74A0-46BF-A8B7-F2C0DA3B6B9F

P478

Q51932708-B02ACE3F-50CB-46FD-8EBE-C81ED5293157

P577

Q51932708-67387803-C668-4F26-849D-57B18F2C2329

P698

Q51932708-5EFFFE95-9D2B-425D-B935-B477560C5937

P921

Q51932708-419FF726-C956-4B7E-A1F2-888581F57C3C

Q51932708-AD793857-8F0B-40D0-B4E6-9211137F7FD0

P356

01.MIB.0000160809.38611.F7

P1433

Inflammatory Bowel Diseases

P1476

Determinants of life satisfaction in inflammatory bowel disease.

@en

P2093

Bodo Klump

http://www.w3.org/2001/XMLSchema#string

Christoph Meisner

http://www.w3.org/2001/XMLSchema#string

Karl-Heinz Janke

http://www.w3.org/2001/XMLSchema#string

Michael Gregor

http://www.w3.org/2001/XMLSchema#string

Winfried Haeuser

http://www.w3.org/2001/XMLSchema#string

P2860

The hospital anxiety and depression scale

Effects of comorbidity on health-related quality-of-life scores: an analysis of clinical trial data.

A review of activity indices and efficacy endpoints for clinical trials of medical therapy in adults with Crohn's disease.

The quality of life in patients with Crohn's disease.

Coated mesalazine (5-aminosalicylic acid) versus sulphasalazine in the treatment of active ulcerative colitis: a randomised trial.

International experiences with the Hospital Anxiety and Depression Scale--a review of validation data and clinical results.

Spirituality, well-being, and quality of life in people with rheumatoid arthritis.

Quality of life in patients with established inflammatory bowel disease: a UK general practice survey.

Quality of life in cancer patients--an hypothesis.

Depression and health-related quality of life.

P304

272-286

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1097/01.MIB.0000160809.38611.F7

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

11

http://www.w3.org/2001/XMLSchema#string

P577

2005-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

15735434

http://www.w3.org/2001/XMLSchema#string

P921

inflammatory bowel diseases